Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

July 18, 2014
Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States

June 13, 2014
Bioniche Life Sciences Inc. to Present at Bloom Burton & Co. Healthcare Investor Conference


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Shareholder Information

Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.

Contact information:

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189

Bioniche financial reports can be downloaded here


Request investor materials by regular mail here

All Bioniche publicly-listed documents can be viewed here

E-mail Alerts

To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy